Innate Pharma
IPHA
#8373
Rank
S$0.21 B
Marketcap
$2.51
Share price
-2.09%
Change (1 day)
-27.60%
Change (1 year)

Earnings for Innate Pharma (IPHA)

Earnings in 2023: -S$11.23 Million

According to Innate Pharma 's latest financial reports the company's current earnings are S$57.37 Million. In 2023 the company made an earning of -S$11.23 Million, an increase over its 2022 earnings that were of -S$83.41 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innate Pharma from 2005 to 2023

Annual earnings

Year Earnings Change
2023-S$11.23 Million-86.54%
2022-S$83.41 Million20.74%
2021-S$69.08 Million4951.09%
2020-S$1.37 Million-111.57%
2019S$11.82 M183.46%
2018S$4.17 M-105.4%
2017-S$77.27 Million-523.25%
2016S$18.25 M-285.64%
2015-S$9.84 Million-69.31%
2014-S$32.05 Million498.29%
2013-S$5.36 Million-5.62%
2012-S$5.68 Million-53.32%
2011-S$12.16 Million-50.1%
2010-S$24.37 Million-13.3%
2009-S$28.11 Million26.36%
2008-S$22.25 Million27.35%
2007-S$17.47 Million63.33%
2006-S$10.7 Million9.81%
2005-S$9.74 Million